$ABCL – Chance to buy in at IPO price
The once hot Peter Theil backed IPO, AbCellera, has been shorted from $72 almost all the way back down to it’s IPO price of $20. Q1 Financials were awesome, with the majority of their revenue coming from royalties from Eli Lilly – now to be fair, I have no clue if these are somewhat one time in nature of they will be ongoing, but in any case, I think the platform that AbCellera has created will lead to many fruitful partnerships over the coming years. I haven’t really done much DD (if any), but remember wanting to get into this back in December, but not wanting to pay the premium on the 100% run-up. I think this could be a great chance to get in at IPO prices for commons or to buy some FDs as this could pop 50%+ on any good news.
via r/wallstreetbets https://ift.tt/3qhG8Zq
June 23, 2021 at 08:39AM